Semaglutide Overview
Semaglutide is a medication used primarily for the management of type 2 diabetes and, more recently, for weight management. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of drugs that mimic the effects of the natural hormone GLP-1 to regulate blood sugar levels and support weight loss.
Semaglutide
Semaglutide 20mg/vial
Semaglutide works by activating GLP-1 receptors in the body, which leads to:
Increased Insulin Secretion: Enhances insulin release from the pancreas in response to meals, helping to lower blood glucose levels.
Reduced Glucagon Release: Decreases the secretion of glucagon, a hormone that raises blood sugar levels.
Delayed Gastric Emptying: Slows down the emptying of the stomach, which helps to control appetite and promote satiety.
Reduced Appetite: Contributes to weight loss by reducing hunger and caloric intake.- Type 2 Diabetes Management: Semaglutide is used to improve glycemic control in adults with type 2 diabetes, either alone or in combination with other diabetes medications
- Weight Management: Semaglutide is also prescribed for weight management in individuals with obesity or overweight conditions. It is used as part of a comprehensive weight management program that includes diet and exercise.
Type 2 Diabetes: Available as a subcutaneous injection in various doses, including 0.25 mg, 0.5 mg, and 1 mg. It is typically administered once weekly.
Weight Management: The dosage for weight management can be higher, often starting at 0.25 mg and increasing to up to 2.4 mg once weekly, depending on the specific formulation and patient response.
Effective Blood Sugar Control: Helps manage blood glucose levels effectively, reducing the risk of diabetes-related complications.
Significant Weight Loss: Demonstrated potential for substantial weight loss in clinical trials, making it a valuable option for managing obesity.
Cardiovascular Benefits: Some studies suggest that semaglutide may have cardiovascular benefits, such as reducing the risk of major adverse cardiovascular events in people with type 2 diabetes.Common side effects of semaglutide may include:
Nausea and Vomiting: Particularly when starting the medication or increasing the dose.
Diarrhea: Can occur, especially during the initial phases of treatment.
Abdominal Pain: Some users report discomfort in the abdominal area.
Constipation: Occasional constipation may also be experienced.
Serious side effects, though less common, include:
Pancreatitis: Inflammation of the pancreas, which requires immediate medical attention.
Thyroid Tumors: There have been concerns about a potential risk of thyroid tumors, including medullary thyroid carcinoma (MTC), based on animal studies.
Kidney Issues: Rare cases of kidney injury have been reported, particularly in individuals with preexisting kidney conditions.
This PRODUCT IS DESIGNATED FOR RESEARCH USE ONLY. It is intended solely for in vitro testing and laboratory experimentation. All information provided on this website is for educational purposes only. The introduction of this product into humans or animals is strictly prohibited by law. Only licensed, qualified professionals should handle this product. It is not intended as a drug, food, or cosmetic and must not be misbranded, misused, or mislabeled as such.
